SUNPHARMA.NS

Sun Pharmaceutical Industries Limited

HealthcareDrug Manufacturers - Specialty & GenericININRPeers →Country macro →

$1,838.30

+0.78%Jun 19, 2026

AI Brief

Market cap

$4.52T

52w range

—

P / E

—

EPS · FY 2026

$47.80

Volume

—

Revenue · FY 2026

$584.62B

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Explain this page

Arphra AIPlain-English read on Sun Pharmaceutical Industries Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$1838.30

Change

+10.57%

Period high

$1905.80

Period low

$1563.30

Period start

$1662.502025-06-23

Through 2026-06-19

Fair value

Football field →

Weighted blend

$1,060.93

— vs spot

Recommendation

n/a

3 of 3 methods

Method spread

0bull0bear

±5% threshold

Candlestick · 1Y

Open in chart workstation →

SUNPHARMA.NS

1,838+10.57%

H 1,917L 1,548MA50 1,787MA200 1,727Avg vol 2.7M

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Consumer Cyclical
+0.85%
Real Estate
+0.78%
Financial Services
+0.60%
Basic Materials
+0.57%
Technology
+0.54%
Communication Services
+0.50%
Energy
+0.39%
Consumer Defensive
+0.36%
Utilities
+0.09%
Industrials
+0.09%
Healthcare
-0.80%

Top industries (issuer's industry highlighted)

Drug Manufacturers - Specialty & Generic
+0.92%
Travel Services
+4.34%
Electronic Gaming & Multimedia
+4.34%
Computer Hardware
+4.14%
Broadcasting
+3.48%
Medical - Equipment & Services
+3.23%
Biotechnology
+3.12%
Manufacturing - Metal Fabrication
+2.68%
Oil & Gas Energy
-2.65%
Software - Services
+2.65%
Independent Power Producers
+2.57%
REIT - Healthcare Facilities
+2.26%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for SUNPHARMA.NS.

Peers

No peer list available for SUNPHARMA.NS.

Total assets

$1.09T

Total debt

$45.96B

Cash & equiv

$116.03B

Operating CF

$128.52B

Free cash flow

$92.42B

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$584.62B	$135.53B	$114.79B	$47.80	+19.64%